Table 2. Significantly differential metabolites of Ganoderma lucidum between two treatments.
Putative identification | m/z | rt (s) | RMM | MF | PT | log2fc(Mn/CK) | p-value |
---|---|---|---|---|---|---|---|
Chavicol | 135.08 | 775.06 | 134.18 | C9H10O | [M+H]+ | 0.69 | 0.0013 |
Palmitoylethanolamide | 300.29 | 882.81 | 299.49 | C18H37NO2 | [M+H]+ | 1.01 | 0.0059 |
D-gluconate | 195.05 | 101.26 | 196.06 | C6H12O7 | [M−H]− | 0.92 | 0.0126 |
Diosmin | 610.17 | 358.73 | 608.54 | C28H32O15 | [M+H]+ | 1.86 | 0.0142 |
N,N-Dimethylaniline | 122.10 | 769.89 | 121.18 | C8H11N | [M+H]+ | 0.95 | 0.0208 |
Benzaldehyde | 107.05 | 775.05 | 106.12 | C7H6O | [M+H]+ | 0.68 | 0.0233 |
2,5-Dihydroxybenzaldehyde | 137.02 | 428.47 | 138.12 | C7H6O3 | [M−H]− | −2.29 | 0.0248 |
Inosine | 267.07 | 254.89 | 268.23 | C10H12N4O5 | [M−H]− | 2.02 | 0.0277 |
3-Methylcrotonyl-CoA | 851.40 | 743.50 | 849.63 | – | [M+H]+ | 1.71 | 0.0310 |
Cellotetraose | 667.23 | 82.59 | 666.58 | C24H42O21 | [M+H]+ | 1.61 | 0.0313 |
N(ω),N(ω)-dimethyl-L-arginine | 203.15 | 84.51 | 202.25 | C8H18N4O2 | [M+H]+ | −0.80 | 0.0347 |
L-(+)-Maltose monnhydrate | 360.15 | 106.87 | 360.31 | – | [M+H]+ | 1.35 | 0.0394 |
Creatine | 261.13 | 358.99 | 131.13 | C4H9N3O2 | [M−H]− | −1.05 | 0.0423 |
Choline | 104.11 | 236.68 | 103.10 | C5H13NO | [M+H]+ | −1.10 | 0.0430 |
5-S-methyl-5-thioadenosine | 298.10 | 310.62 | 297.33 | C11H15N5O3S | [M+H]+ | 0.85 | 0.0431 |
Nipecotic acid | 130.09 | 65.12 | 129.08 | C6H11NO2 | [M+H]+ | −0.83 | 0.0490 |
Note:
m/z, mass charge ratio; rt, retention time; RMM, relative molecular mass; MF, molecular formula; PT, precursor type.